Morgan Stanley analyst Erin Wright maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $612.00. The company’s shares closed last Friday at $505.59.

McKesson (MCK) closed at $488.78 in the latest trading session, marking a -1.95% move from the prior day. This change lagged the S&P 500's daily gain of 0.01%. Elsewhere, the Dow saw an upswing of ...

San Francisco, CA-based McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: MCK boasts a Value Style Score of A and VGM Score ...

The purchases in question are McKesson Corporation’s $2.5 billion bid for a controlling stake in the Florida Cancer Specialists & Research Institute’s management services organization ...

Issue: Whether the Hobbs Act required the district court in this case to accept the Federal Communications Commission’s legal interpretation of the Telephone Consumer Protection Act. Jun 18 2024 ...

(Bloomberg) -- Several publicly traded drug distributors are vying to buy Florida Cancer Specialists & Research Institute, a privately held operator of oncology clinics, people familiar with the ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

As of October 18, 2024, McKesson Corp had a $66.0 billion market capitalization, putting it in the 96th percentile of companies in the Health Care Providers & Services industry. Currently, McKesson ...